Armen Shanafelt Aeglea Bio Therapeutics, Inc. (AGLE) insider trading activity

AGLE Quotes by TradingView

Armen Shanafelt is Director of Aeglea BioTherapeutics, Inc.. Currently has a direct ownership of 150,000 shares of AGLE, which is worth approximately $4.15 Million. The most recent transaction as insider was on Dec 13, 2021, when has been sold 14,685 shares (Common Stock) at a price of $3.65 per share, resulting in proceeds of $53,600. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 150K
0% 3M change
0% 12M change
Total Value Held $4.15 Million

Armen Shanafelt Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 13 2021
BUY
Open market or private purchase
$53,600 $3.65 p/Share
14,685 Added 8.92%
150,000 Common Stock
Dec 10 2021
BUY
Open market or private purchase
$49,333 $3.65 p/Share
13,516 Added 9.08%
135,315 Common Stock
Dec 09 2021
BUY
Open market or private purchase
$447,002 $3.67 p/Share
121,799 Added 50.0%
121,799 Common Stock

Also insider at

SURF
Surface Oncology, Inc. Healthcare
Director
AS

Armen Shanafelt

Director
Indianapolis, IN

Track Institutional and Insider Activities on AGLE

Follow Aeglea BioTherapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AGLE shares.

Notify only if

Insider Trading

Get notified when an Aeglea Bio Therapeutics, Inc. insider buys or sells AGLE shares.

Notify only if

News

Receive news related to Aeglea BioTherapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AGLE